Short Note on Post-operative Hypoparathyroidism

Journal of Health & Medical Informatics

ISSN: 2157-7420

Open Access

Perspective - (2022) Volume 13, Issue 2

Short Note on Post-operative Hypoparathyroidism

Shiva Mani*
*Correspondence: Shiva Mani, Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea, Tel: +9232716844, Email:
Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea

Received: 05-Feb-2022, Manuscript No. jhmi-22-55622; Editor assigned: 07-Feb-2022, Pre QC No. P-55622; Reviewed: 10-Feb-2022, QC No. Q-55622; Revised: 15-Feb-2022, Manuscript No. R-55622; Published: 20-Feb-2022 , DOI: DOI: 10.37421/jhmi.2022.13.408
Citation: Mani, Shiva. “Short Note on Post-operative Hypoparathyroidism.” J Health Med Informat 13 (2022): 408. DOI: 10.37421/jhmi.2022.13.408
Copyright: © 2022 Mani S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Hypoparathyroidism occurs when the parathyroid glands are unable to maintain calcium homeostasis due to a lack of PTH secretion or resistance. Transient and permanent hypoparathyroidism are most commonly seen as complications of neck surgery, resulting from parathyroid devascularization, unintentional resection, or parathyroid coagulation [1].


Although treatment strategies for transient and permanent hypoparathyroidism differ, the classical approach involves calcium and vitamin D or analogue supplementation with the primary goal of achieving low normal serum calcium and normal serum phosphorus. There are several calcium and vitamin D preparations on the market for the treatment of symptomatic hypoparathyroidism [2]. It is critical to consider the pharmocodynamics, tissue potency, rapidity of action, and ease of reversal of toxicity when selecting the appropriate vitamin D sterol for treatment. The limitations of conventional therapy, such as a narrow therapeutic window and a proclivity for hypercalciuria and hypercalcemia, have prompted researchers to look into alternatives, such as PTH replacement and parathyroid gland autotransplantation.

If left untreated, post-thyroidectomy hypoparathyroidism is an unintended sequela that can cause transient or permanent symptoms ranging from tingling sensations to severe breathing difficulties. The incidence of iatrogenic hypoparathyroidism has been reported to range from 7% to 37%, a range that is too wide to be indicative [3]. This variation in incidence is caused not only byinter-operator variation, but also by differences in thyroid operations performed in different medical communities.

South Korea's thyroid surgery pattern differs slightly from that of the rest of the world. Because medical services are easily accessible to the general public in South Korea, thyroid cancer is often detected at an early stage, and its incidence is very high, at around 51.1 per 100,000 people in 2017. Furthermore, due to South Korea's high density and urban orientation, approximately 68.5 percent of thyroid cancer operations in 2019 were performed by high volume surgeons at tertiary medical centres [4].

The concentration of thyroid patients in large tertiary care centres suggests that a thorough analysis of their data can provide meaningful and generalizable results about the incidence of and risk factors for thyroid cancer and postthyroidectomy hypoparathyroidism. Hospital-specific Clinical Data Warehouses (CDWs), which were created to help with data analysis, are platforms that are used to integrate complex data sources using specialised analytical tools. These in-hospital CDWs can be used for financial, administrative, clinical, and research purposes, including hypothesis generation and retrospective analysis [5]. However, combining CDW data from multiple tertiary centres necessitates the use of a Common Data Model (CDM).


Long-term vitamin D or analogue supplementation and oral calcium are the mainstays of postoperative hypoparathyroidism management; however, PTH replacement strategies with either PTH or parathyroid gland auto-transplantation are emerging as alternative strategies to avoid the complications of conventional therapy.


  1. Clarke, Bart L, Edward M Brown, Michael T Collins, and Harald Jüppner, et al. “Epidemiology and diagnosis of hypoparathyroidism.” J Clin Endocrinol Metab 101 (2016): 2284–2299.
  2. Google Scholar, Crossref, Indexed at

  3. Kakava, Kassiani, Symeon Tournis, Georgios Papadakis, and Ioannis Karelas, et al. “Postsurgical hypoparathyroidism: a systematic review.” In Vivo 30 (2016): 171–179.
  4. Google Scholar, Indexed at

  5. Powers, Julia, Joy Karen, Aimee Ruscio, and Hjalmar Lagast. “Prevalence and incidence of hypoparathyroidism in the United States using a large claims database.” J Bone Miner Res 28 (2013): 2570–2576.
  6. Google Scholar, Crossref

  7. Asari, R, C Passler, K Kaczirek, and C Scheuba, et al. “Hypoparathyroidism after total thyroidectomy: a prospective study.” Arch Surg 143 (2008): 132–138.
  8. Google Scholar, Crossref

  9. Agarwal, Pooja, Mahesh Prakash, Manphool Singhal, and Sanjay Kumar Bhadada, et al. “To assess vascular calcification in the patients of hypoparathyroidism using multidetector computed tomography scan.” Indian J Endocrinol Metab 19 (2015): 785–790.
  10. Google Scholar, Crossref

Google Scholar citation report
Citations: 2128

Journal of Health & Medical Informatics received 2128 citations as per Google Scholar report

Journal of Health & Medical Informatics peer review process verified at publons

Indexed In

arrow_upward arrow_upward